Drug Type Antibody drug conjugate (ADC) |
Synonyms anti-FcRL5-SPDB-DM4 |
Target |
Mechanism FCRL5 inhibitors(Fc receptor-like protein 5 inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC38H54ClN3O10S |
InChIKeyJFCFGYGEYRIEBE-UHFFFAOYSA-N |
CAS Registry796073-69-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Discovery | US | 01 Jan 2012 |